Risk Framing in Cardiovascular Medicine I
Mayo Clin Proc
.
2020 Nov;95(11):2568-2569.
doi: 10.1016/j.mayocp.2020.09.008.
Authors
Taher Modarressi
1
,
Arsalan Derakhshan
2
Affiliations
1
Diabetes & Endocrine Associates of Hunterdon, Hunterdon Medical Center, Flemington, NJ.
2
Division of General Internal Medicine, University Hospitals Cleveland Medical Center, Cleveland, OH.
PMID:
33153646
DOI:
10.1016/j.mayocp.2020.09.008
No abstract available
Publication types
Letter
Comment
MeSH terms
Cardiovascular Agents*
Humans
Medicine*
Patient-Centered Care
Substances
Cardiovascular Agents